Pain management is anticipated to lead the muscle stimulation devices market at 47.0% share of application in 2026, followed by TENS devices as expected at 38.0% share of product in 2026. Adoption rests on recurring equipment replacement and pain-treatment requirements, with certification costs and product requalification forming principal barriers.